Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths

July 18, 2026 - 04:01

Federal regulators have escalated their warning about a specific vascular device, now telling doctors and hospitals to send it back to the manufacturer. The updated guidance from the Food and Drug Administration marks a shift from earlier advice, which had allowed clinicians to keep using the equipment if no suitable alternative was available.

The device, used in certain heart and blood vessel procedures, has been linked to three patient deaths. Investigators also found dozens of reports of serious injuries and malfunctions. The FDA initially issued a recall but stopped short of demanding an immediate return, giving medical teams some discretion. That changed with the latest alert, which stresses that the risks now outweigh any potential benefits of continued use.

The agency is asking all facilities to inspect their inventories and quarantine any remaining units. They are also instructing clinicians to switch to other approved products. The manufacturer has been cooperating with the recall and is providing instructions for returning the devices.

Patient safety groups have praised the stronger stance, arguing that the earlier "use if necessary" policy created confusion. The FDA says it will continue to monitor the situation and may issue further updates as new information comes in. For now, the message is clear: do not use it, send it back.